Literature DB >> 17565727

Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.

Elisabeth Piault1, Christopher J Evans, Derek Espindle, Zoe Kopp, Linda Brubaker, Paul Abrams.   

Abstract

AIMS: To develop and validate a measure of patient satisfaction with treatment in overactive bladder: the Overactive Bladder Satisfaction Questionnaire (OAB-S).
METHODS: Development of the questionnaire included a comprehensive literature review, development of a conceptual model, item elicitation and cognitive debriefing interviews with US-English and US-Spanish patients, and assessment of the questionnaire's translatability in other languages. Psychometric validation of the questionnaire was run on a longitudinal, non-randomized study involving 201 OAB patients. Analyses included construct validity, concurrent validity, tests of reliability, known-group validity, and responsiveness (exploratory).
RESULTS: The OAB-S is a patient-completed questionnaire including five scales: OAB Control Expectations (ten items); Impact on Daily Living with OAB (ten items); OAB Control (ten items); OAB Medication Tolerability (six items); and Satisfaction with Control (ten items) and five single-item overall assessments of patient's fulfillment of OAB medication expectations, interruption of day-to-day life due to OAB, overall satisfaction with OAB medication; willingness to continue OAB medication and improvement in day-to-day life due to OAB medication. The hypothesized structure of the questionnaire was supported by statistical analyses. Internal consistency reliability coefficients (ranging from 0.76 to 0.94) and test-retest reliability coefficients (ranging from 0.72 to 0.87) were good for all dimensions. All dimensions except tolerability discriminated well according to self-reported OAB severity level and incontinence status.
CONCLUSION: The OAB-S is a valid, comprehensive instrument to assess satisfaction with treatment of OAB based on independent scales that have demonstrated satisfactory psychometric performance. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17565727     DOI: 10.1002/nau.20455

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  21 in total

1.  Usefulness of translatability assessment: results from a retrospective study.

Authors:  Katrin Conway; Catherine Acquadro; Donald L Patrick
Journal:  Qual Life Res       Date:  2013-11-22       Impact factor: 4.147

Review 2.  Patient-reported outcomes and different approaches to urinary parameters in overactive bladder: what should we measure?

Authors:  Vik Khullar
Journal:  Int Urogynecol J       Date:  2011-10-20       Impact factor: 2.894

3.  Diagnosis of incontinence.

Authors:  Michael B Chancellor; Kenneth M Peters
Journal:  Rev Urol       Date:  2008

4.  Objective Evaluation of Overactive Bladder: Which Surveys Should I Use?

Authors:  Michael Shy; Sophie G Fletcher
Journal:  Curr Bladder Dysfunct Rep       Date:  2013-03-01

5.  Long-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment.

Authors:  Rachel Hess; Alison J Huang; Holly E Richter; Chiara C Ghetti; Vivian W Sung; Elizabeth Barrett-Connor; W Thomas Gregory; JoAnn V Pinkerton; Catherine S Bradley; Stephen R Kraus; Rebecca G Rogers; Leslee L Subak; Karen C Johnson; Lily A Arya; Michael Schembri; Jeanette S Brown
Journal:  Am J Obstet Gynecol       Date:  2013-05-06       Impact factor: 8.661

6.  Does conservative management really benefit patients with OAB?

Authors:  Philip E V Van Kerrebroeck
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

7.  Defining efficacy in the treatment of overactive bladder syndrome.

Authors:  Sagar Shah; Victor W Nitti
Journal:  Rev Urol       Date:  2009

8.  Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire.

Authors:  Linda Brubaker; Vik Khullar; Elisabeth Piault; Christopher J Evans; Tamara Bavendam; James Beach; Yating Yeh; Zoe S Kopp; Con J Kelleher; Jeffrey Trocio
Journal:  Int Urogynecol J       Date:  2011-03-04       Impact factor: 2.894

Review 9.  Subjective measures of efficacy and quality of life in overactive bladder syndrome.

Authors:  Aimee Nguyen; Peter K Sand
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

10.  Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study.

Authors:  J J Wyndaele; E R Goldfischer; J D Morrow; J Gong; L J Tseng; Z Guan; M S Choo
Journal:  Int J Clin Pract       Date:  2009-04       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.